Neuropathy refers to symptoms caused by nerve damage, such as severe and chronic pain, tingling, numbness, cramps, and weakness. Physical therapy may be able to help reduce the symptoms of neuropathy.

This week we are going to discuss one of the most often asked questions about peripheral neuropathy: If this is a permanent condition, why prescribe therapy? Many patients develop loss of balance and ...

Shock wave therapy uses sound energy waves to improve blood flow and promote healing. This treatment has been linked to reduced pain and overall symptom improvement for people with diabetic neuropathy ...

SAN FRANCISCO ― Massage therapy can provide symptomatic relief for chronic chemotherapy-induced peripheral neuropathy (CIPN), a new study suggests. The number of weekly massage sessions that a patient ...

As summer enters with a bang in South Texas, many have plans to head to the beach with family and friends. Sadly, for many, this idea is not a dream but a nightmare. For the population who suffer from ...

Mercy Family Health in DuBois, PA, now offers StemWave acoustic wave therapy for plantar fasciitis and foot neuropathy. The ...

Painful diabetic neuropathy is a common complication of diabetes mellitus. Based on strong evidence, recently published guidelines suggest that pregabalin should be offered as first-line therapy in ...

Photobiomodulation, which uses low-level red infrared light, may reduce the severity of chemotherapy-induced peripheral neuropathy (CIPN) and increase mobility in patients with cancer, new research ...

Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to ...

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study) Among patients with stage ...

Of 4,554 patients who received at least one taxane dose, grade 2 to 4 neuropathy developed in 18%, 22%, 15%, and 13% of patients in the P3, P1, D3, and D1 arms, respectively. In a model that included ...